IP Library Granted Patent US 6,858,601
Granted Patent B2
US 6,858,601 · App. 10/623,954 · Granted Feb 22, 2005

Parasiticidal formulation for animals

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,858,601
App. No.
10/623,954
Granted
Feb 22, 2005
Kind
B2
Abstract

A formulation for treating and preventing parasite infestations in horses, dogs, cats, and other animals is provided. This formulation includes a cestocidal agent, wherein the cestocidal agent is pyrantel, morantel, any salt thereof, or any combination thereof. Preferably the formulation additionally includes an edible non-aqueous liquid and a thickening agent. The formulation of the present invention allows for a high concentration of cestocidal agent.

Claims (40)

1. A parasiticidal formulation, comprising:

a cestocidal agent, wherein said cestocidal agent is selected from the group consisting of pyrantel, morantel, and combinations thereof; and

an edible, non-aqueous liquid,

wherein said cestocidal agent is present in said formulation in an amount equal to or greater than about 17% w/w and wherein said formulation comprises no more than about 10% w/w water.

2. The formulation of claim 1 , wherein said cestocidal agent is present in said formulation in an amount between about 17% and about 23% w/w.

3. The formulation of claim 2 , wherein said cestocidal agent is present in said formulation in an amount equal to or greater than about 19% w/w.

4. The formulation of claim 3 , wherein said cestocidal agent is present in said formulation in an amount equal to about 19% w/w.

5. The formulations of claim 2 , wherein said cestocidal agent is present in said formulation in an amount equal to or greater than about 21% w/w.

6. The formulation of claim 5 , wherein said cestocidal agent is present in said formulation in an amount equal to about 21% w/w.

7. The formulation of claim 1 , wherein said cestocidal agent is present as a salt, and said salt is present in said formulation in an amount equal to or greater than about 50% w/w.

8. The formulation of claim 7 , wherein said salt is present in said formulation in an amount between about 50% and about 70% w/w.

9. The formulation of claim 8 , wherein said salt is present in said formulation in an amount between about 50% and about 65% w/w.

10. The formulation of claim 7 , wherein said salt is present in said formulation in an amount equal to about 54% w/w.

11. The formulation of claim 7 , wherein said salt is present in said formulation in an amount equal to about 62% w/w.

12. The formulation of claim 7 , wherein said salt is selected from the group consisting of pyrantel pamoate, pyrantel tartrate and any combination thereof.

13. The formulation of claim 12 , wherein said salt is pyrantel pamoate.

14. The formulation of claim 1 , further comprising:

a thickening agent.

15. The formulation of claim 14 , further comprising:

an agent effective against nematodes and obligate parasitic flies selected from the group consisting of an avermectin, a milbemycin and combinations thereof.

16. The formulation of claim 1 , further comprising:

a preservative.

17. The formulation of claim 1 , wherein said formulation is a paste.

18. The formulation of claim 17 , wherein said formulation is a paste for oral administration.

19. A parasiticidal formulation for oral administration, comprising:

a cestocidal agent, wherein said cestocidal agent is selected from the group consisting of salts of pyrantel and morantel and any combinations thereof; and

an edible, non-aqueous liquid,

wherein said salt is present in said formulation in an amount equal to or greater than 50% w/w and wherein said formulation comprises no more than about 10% w/w water.

20. The formulation of claim 19 , wherein said formulation is a paste.

21. The formulation of claim 20 , wherein said formulation further comprises:

a thickening agent.

22. The formulation of claim 20 , wherein said salt is pyrantel pamoate.

23. A parasiticidal formulation, comprising:

a salt of pyrantel, wherein said salt is present in said formulation in an amount equal to or greater than 50% w/w; and

an edible, non-aqueous liquid,

wherein said formulation is a paste for oral administration and wherein said formulation comprises no more than about 10% w/w water.

24. A method of treating parasite infestations in animals, comprising:

providing a parasiticidal formulation comprising a cestocidal agent selected from the group consisting of pyrantel, morantel, and combinations thereof and an edible, non-aqueous liquid, wherein said cestocidal agent is present in said formulation in an amount equal to or greater than about 17% w/w; and wherein said formulation comprises no more than about 10% w/w water; and

administering said formulation to said animal in a therapeutically effective amount.

25. The method of claim 24 , wherein said formulation is administered to equine to treat Anoplocephala perfoliata infestation.

Assignments (4)
MERGER Recorded Jun 25, 2008
From: PHOENIX SCIENTIFIC, INC.
To: PSI HOLDINGS, INC.
Reel/Frame 021147/0057 →
CHANGE OF NAME Recorded Jun 25, 2008
From: PSI HOLDINGS, INC.
To: IVX ANIMAL HEALTH, INC.
Reel/Frame 021147/0069 →
CHANGE OF NAME Recorded Jan 10, 2006
From: PSI HOLDINGS, INC.
To: IVX ANIMAL HEALTH, INC.
Reel/Frame 016996/0060 →
NUNC PRO TUNC ASSIGNMENT Recorded Jan 5, 2006
From: PHOENIX SCIENTIFIC, INC.
To: PSI HOLDINGS, INC.
Reel/Frame 016967/0952 →